Ono Pharmaceutical (4528) · InitiativeRestated
Nature-related risk management based on the TNFD Recommendations
First written in FY2024. 1 of 2 entries say "Restated". Latest entry: FY2025.
2entries
2years
0from disclosures
How it moved
Same theme, other companies
TNFD-Based Natural Capital and Biodiversity Risk Assessment, Disclosure and ConservationA theme 28 companies write about · 5 as a headwind · 21 as a tailwind
0 other companies' latest entry also says "Restated".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 28 companies compared. The sentences above are computed from all 28.Full recordFilings, disclosures and news, newest first
- FY2025RestatedAnnual report
「In addition, based on the recommendations of the Task Force on Climate-related Financial Disclosures (TCFD) and the Taskforce on Nature-related Financial Disclosures (TNFD), we identify climate-related and nature-related risks, consider response measures, and disclose relevant information.」
The company continues to identify climate-related and nature-related risks, consider response measures, and disclose information based on the TCFD and TNFD recommendations. - FY2024First statedAnnual report
「In addition, we have begun considering the identification of nature-related risks and measures to address them based on the recommendations of the Taskforce on Nature-related Financial Disclosures (TNFD).」
In addition to existing environmental initiatives addressing decarbonization, the water cycle and resource circulation, the company began identifying nature-related risks and considering response measures.